EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A pragmatic reevaluation of the efficacy of nonhuman primate optogenetics for psychiatry

Eliza Bliss-Moreau, Vincent D Costa, Mark G Baxter

Oxford Open Neuroscience · 01.05.2022 · 1

DOI: 10.1093/oons/kvac006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oxford Open Neuroscience, online erschienen am 29.04.2022. Verfasst von Eliza Bliss-Moreau und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, University of California Davis, CA 95616, USA. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Translational neuroscience is committed to generating discoveries in the laboratory that ultimately can improve human lives. Optogenetics has received considerable attention because of its demonstrated promise in rodent brains to manipulate cells and circuits. In a recent report, Tremblay et al. [28] introduce an open resource detailing optogenetic studies of the nonhuman primate (NHP) brain and make robust claims about the translatability of the technology. We propose that their quantitative (e.g. a 91% success rate) and theoretical claims are questionable because the data were analyzed at a level relevant to the rodent but not NHP brain. Injections were clustered within a few monkeys in a few studies in a few brain regions, and their definitions of success were not clearly relevant to human neuropsychiatric disease. A reanalysis of the data with a modified definition of success that included a behavioral and biological effect revealed a 62.5% success rate that was lower when considering only strong outcomes (53.1%). This calls into question the current efficacy of optogenetic techniques in the NHP brain and suggests that we are a long way from being able to leverage them in ‘the service of patients with neurological or psychiatric conditions’ as the Tremblay report claims.

Schlagwörter

Stichwörter der Autor:innen

nonhuman primatesopen scienceoptogeneticstranslational neurosciencetranslational psychiatry

Autor:innen und Institutionen

  • Department of Psychology, University of California Davis, CA 95616, USA.
  • California National Primate Research Center, University of California Davis, CA 95616, USA.
  • Department of Behavioral Neuroscience, Oregon Health Sciences University, OR 97239, USA.
  • Oregon National Primate Research Center, Oregon Health Sciences University, OR 97239, USA.
  • Nash Family Department of Neuroscience, Icahn School of Medicine at Mount Sinai, NY 10029-5674, USA.

Zitieren

APA

Bliss-Moreau, E., Costa, V. D., & Baxter, M. G. (2022). A pragmatic reevaluation of the efficacy of nonhuman primate optogenetics for psychiatry. Oxford Open Neuroscience, 1. https://doi.org/10.1093/oons/kvac006

Vancouver

Bliss-Moreau E, Costa VD, Baxter MG. A pragmatic reevaluation of the efficacy of nonhuman primate optogenetics for psychiatry. Oxford Open Neuroscience. 2022;1. doi:10.1093/oons/kvac006

BibTeX
@article{BlissMoreau2022,
  author = {Bliss-Moreau, Eliza and Costa, Vincent D and Baxter, Mark G},
  title = {A pragmatic reevaluation of the efficacy of nonhuman primate optogenetics for psychiatry},
  journal = {Oxford Open Neuroscience},
  year = {2022},
  volume = {1},
  doi = {10.1093/oons/kvac006}
}
Kostenlos starten →